Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

KTTA Pasithea Therapeutics Corporation

5,30

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:05:40

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Pasithea Therapeutics (NASDAQ:KTTA)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Pasithea Therapeutics Charts.

Pasithea Therapeutics (NASDAQ:KTTA)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Pasithea Therapeutics Charts.

News Pasithea Therapeutics Corporation

Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for PAS-004 in Ongoing Phase 1 Clinical Trial
Donnerstag 13 Juni 2024 (2 Wochen vor) • GlobeNewswire Inc.

Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer Cell Lines and Demonstrates Superior Activity in Xenograft Studies at 2024 ASCO Annual Meeting
Dienstag 28 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Pasithea Therapeutics Announces PAS-004 Abstract Accepted for Poster Presentation at 2024 ASCO Annual Meeting
Montag 29 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1 Trial Evaluating PAS-004 in RAS, NF1 and RAF Mutated Cancers
Mittwoch 24 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004
Dienstag 13 Februar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 18 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position
Montag 8 Januar 2024 (6 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 2 Januar 2024 (6 Monate vor) • Edgar (US Regulatory)

Weitere Pasithea Therapeutics Corporation News-Artikel

Abingworth Bioventures Vi

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen